Skip to main content

Table 4 The relationship between lncRNA-ANRIL and SOX9 expression levels and the clinicopathology in patients with glioma

From: Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

Factors n Relative expression of lncRNA-ANRIL t P Relative expression of SOX9 t P
Tumor grade    8.650 <0.001   6.621 <0.001
Grade I to II 79 2.47±0.35    0.39±0.04   
Grade III to IV 63 2.02±0.27    0.44±0.05   
Tumor diameter(cm)    3.602 <0.001   6.638 <0.001
≥4.51 77 2.29±0.31    0.45±0.04   
<4.51 65 2.11±0.28    0.41±0.03   
Distant metastasis    5.351 <0.001   5.027 <0.001
Yes 39 2.38±0.27    0.43±0.06   
No 103 2.13±0.24    0.38±0.05   
Family history of glioma    2.166 0.032   2.113 0.036
Yes 19 2.26±0.37    0.36±0.05   
No 123 2.09±0.31    0.40±0.08